The future of r-HuEPOESCHBACH, J. W.Nephrology, dialysis, transplantation (Print). 1995, Vol 10, pp 96-109, issn 0931-0509, SUP2Conference Paper

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietinESCHBACH, J. W.Journal of perinatal medicine. 1989, Vol 35, Num 1, pp 134-148, issn 0300-5577Article

Treatment of the anemia of chronic renal failure with recombinant human erythropoietinADAMSON, J. W; ESCHBACH, J. W.Annual review of medicine. 1990, Vol 41, pp 349-360, issn 0066-4219Article

Erythropoietin 1991 : an overviewESCHBACH, J. W.American journal of kidney diseases. 1991, Vol 18, Num 4, pp 3-9, issn 0272-6386, SUP1Conference Paper

Anemia of end-stage renal disease (ESRD)ESCHBACH, J. W; ADAMSON, J. W.Kidney international. 1985, Vol 28, Num 1, pp 1-5, issn 0085-2538Article

The anemia of chronic renal failure : pathophysiology and effects of recombinant erythropoeitin. DiscussionESCHBACH, J. W; HALEY, N. R; ADAMSON, J. W et al.Contributions to nephrology. 1990, Vol 78, pp 24-37, issn 0302-5144, 14 p.Conference Paper

Management of iron deficiency in renal anemia : guidelines for the optimal therapeutic approach in erythropoietin-treated patientsDRÜEKE, T. B; BARANY, P; CAZZOLA, M et al.Clinical nephrology. 1997, Vol 48, Num 1, pp 1-8, issn 0301-0430Article

Recombinant human erythropoietin in anemic patients with end-stage renal disease: results of a phase III multicenter clinical trialESCHBACH, J. W; ABDULHADI, M. H; KORBET, S et al.Annals of internal medicine. 1989, Vol 111, Num 12, pp 992-1000, issn 0003-4819Article

Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificityDELWICHE, F; SEGAL, G. M; ESCHBACH, J. W et al.Kidney international. 1986, Vol 29, Num 3, pp 641-648, issn 0085-2538Article

Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative clinical practice guidelines : Description, findings, and implicationsSTEINBERG, E. P; EKNOYAN, G; LEVIN, N. W et al.American journal of kidney diseases. 2000, Vol 36, Num 1, pp 1-11, issn 0272-6386Article

Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patientsPAGANINI, E. P; ESCHBACH, J. W; LAZARUS, J. M et al.American journal of kidney diseases. 1995, Vol 26, Num 2, pp 331-340, issn 0272-6386Article

Treatment of the anemia of progressive renal failure with recombinant human erythropoietinESCHBACH, J. W; KELLY, M. R; HALEY, N. R et al.The New England journal of medicine. 1989, Vol 321, Num 3, pp 158-163, issn 0028-4793Article

The anaemia of chronic renal failure in sheep: studies in vitroMLADENOVIC, J; ESCHBACH, J. W; GARCIA, J. F et al.British journal of haematology. 1984, Vol 58, Num 3, pp 491-500, issn 0007-1048Article

A comparison of the responses to recombinant human erythropoietin in normal and uremic subjectsESCHBACH, J. W; HALEY, N. R; EGRIE, J. C et al.Kidney international. 1992, Vol 42, Num 2, pp 407-416, issn 0085-2538Conference Paper

The anemia of chronic renal failure in sheep: response to erythropoietin-rich plasma in vivoESCHBACH, J. W; MLADENOVIC, J; GARCIA, J. F et al.The Journal of clinical investigation. 1984, Vol 74, Num 2, pp 434-441, issn 0021-9738Article

The long-term effects of recombinant human erythropoietin on the cardiovascular systemESCHBACH, J. W; AQUILING, T; HALEY, N. R et al.Clinical nephrology. 1992, Vol 38, pp S98-S103, issn 0301-0430, SUP1Conference Paper

Hypertension following erythropoietin therapy in anemic hemodialysis patientsBUCKNER, F. S; ESCHBACH, J. W; HALEY, N. R et al.American journal of hypertension. 1990, Vol 3, Num 12, pp 947-955, issn 0895-7061, 9 p., p.1Article

Effects of erythropoietin on strength and functional status of patients on hemodialysisGUTHRIE, M; CARDENAS, D; ESCHBACH, J. W et al.Clinical nephrology. 1993, Vol 39, Num 2, pp 97-102, issn 0301-0430Article

The anemia of end-stage renal disease: hematopoietic progenitor cell responseSEGAL, G. M; ESCHBACH, J. W; EGRIE, J. C et al.Kidney international. 1988, Vol 33, Num 5, pp 983-988, issn 0085-2538Article

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinical trialESCHBACH, J. W; EGRIE, J. C; DOWNING, M. R et al.The New England journal of medicine. 1987, Vol 316, Num 2, pp 73-78, issn 0028-4793Article

Erythropoietin kinetics in normal and uremic sheepMLADENOVIC, J; ESCHBACH, J. W; KOUP, J. R et al.The Journal of laboratory and clinical medicine. 1985, Vol 105, Num 6, pp 659-663, issn 0022-2143Article